全球首款CD7 CAR-T儿童适应证一期临床启动;国家药监局批准中药创新药枣仁宁心滴丸上市丨医药早参

每日经济新闻
Jun 08

丨2026年6月8日星期一丨  NO.1 安科生物:全球首款CD7 CAR-T儿童适应证一期临床启动  6月6日,据安科生物消息,复发难治T淋巴母细胞白血病/淋巴瘤是儿童血液肿瘤中极具侵袭性的恶性疾病,患儿在常规化疗、造血干细胞移植失败后,临床可选方案寥寥。6月4日,安科生物参股公司博生吉医药自主研发的全球首款进入临床阶段的靶向CD7自体CAR-T产品PA3-17儿童适应证临床试验启动会在组长单位...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10